These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 26556035

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies.
    Singh N, Piskorz AM, Bosse T, Jimenez-Linan M, Rous B, Brenton JD, Gilks CB, Köbel M.
    J Pathol; 2020 Mar; 250(3):336-345. PubMed ID: 31829441
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
    Hussein YR, Weigelt B, Levine DA, Schoolmeester JK, Dao LN, Balzer BL, Liles G, Karlan B, Köbel M, Lee CH, Soslow RA.
    Mod Pathol; 2015 Apr; 28(4):505-14. PubMed ID: 25394778
    [Abstract] [Full Text] [Related]

  • 5. Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
    Cybulska P, Paula ADC, Tseng J, Leitao MM, Bashashati A, Huntsman DG, Nazeran TM, Aghajanian C, Abu-Rustum NR, DeLair DF, Shah SP, Weigelt B.
    Gynecol Oncol; 2019 Sep; 154(3):516-523. PubMed ID: 31340883
    [Abstract] [Full Text] [Related]

  • 6. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I, D'Angelo E, Corominas M, Gonzalez A, Prat J.
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular Genetics of Endometrial Carcinoma.
    Bell DW, Ellenson LH.
    Annu Rev Pathol; 2019 Jan 24; 14():339-367. PubMed ID: 30332563
    [Abstract] [Full Text] [Related]

  • 9. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.
    Am J Surg Pathol; 2009 Oct 24; 33(10):1504-14. PubMed ID: 19623034
    [Abstract] [Full Text] [Related]

  • 10. Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.
    Brett MA, Atenafu EG, Singh N, Ghatage P, Clarke BA, Nelson GS, Bernardini MQ, Köbel M.
    Int J Gynecol Pathol; 2021 Mar 01; 40(2):116-123. PubMed ID: 32265358
    [Abstract] [Full Text] [Related]

  • 11. Use of mutation profiles to refine the classification of endometrial carcinomas.
    McConechy MK, Ding J, Cheang MC, Wiegand K, Senz J, Tone A, Yang W, Prentice L, Tse K, Zeng T, McDonald H, Schmidt AP, Mutch DG, McAlpine JN, Hirst M, Shah SP, Lee CH, Goodfellow PJ, Gilks CB, Huntsman DG.
    J Pathol; 2012 Sep 01; 228(1):20-30. PubMed ID: 22653804
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP, van der Putten LJ, van Tilborg AA, Lurkin I, Zwarthoff EC, Pijnenborg JM, van den Berg-van Erp SH, Snijders MP, Bulten J, Visscher DW, Dowdy SC, Massuger LF.
    Gynecol Oncol; 2015 May 01; 137(2):245-51. PubMed ID: 25773202
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN, McConechy MK, Köbel M, Han G, Rouzbahman M, Davidson B, Irving J, Ali RH, Leung S, McAlpine JN, Oliva E, Nucci MR, Soslow RA, Huntsman DG, Gilks CB, Lee CH.
    Am J Surg Pathol; 2013 Sep 01; 37(9):1421-32. PubMed ID: 24076778
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M, Nakayama K, Nakamura K, Ono R, Yamashita H, Ishibashi T, Minamoto T, Iida K, Razia S, Ishikawa N, Kyo S.
    Hum Pathol; 2019 Mar 01; 85():92-100. PubMed ID: 30448219
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.